These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 27037000)
1. miR-539 inhibits prostate cancer progression by directly targeting SPAG5. Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000 [TBL] [Abstract][Full Text] [Related]
2. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838 [TBL] [Abstract][Full Text] [Related]
3. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma. Guo J; Wang M; Liu X J Exp Clin Cancer Res; 2015 Sep; 34(1):91. PubMed ID: 26338045 [TBL] [Abstract][Full Text] [Related]
5. miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. Guo J; Liu X; Wang M Biochem Biophys Res Commun; 2015 Sep; 464(4):1302-1308. PubMed ID: 26231797 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117 [TBL] [Abstract][Full Text] [Related]
7. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1. Liang X; Li Z; Men Q; Li Y; Li H; Chong T Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091 [TBL] [Abstract][Full Text] [Related]
8. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561 [TBL] [Abstract][Full Text] [Related]
10. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/β-catenin signalling. Yang T; Tian S; Wang L; Wang Y; Zhao J Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):687-695. PubMed ID: 31792998 [TBL] [Abstract][Full Text] [Related]
13. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer. Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862 [TBL] [Abstract][Full Text] [Related]
14. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029 [TBL] [Abstract][Full Text] [Related]
15. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. Xiang J; Bian C; Wang H; Huang S; Wu D J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908 [TBL] [Abstract][Full Text] [Related]
17. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer. Kato M; Goto Y; Matsushita R; Kurozumi A; Fukumoto I; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N Int J Oncol; 2015 Aug; 47(2):710-8. PubMed ID: 26063484 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]